has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

Treatment for asthma and COPD exacerbations have not changed in 50 years despite causing 3.8 million deaths worldwide a year combined. "Benralizumab is a safe and effective drug already used to ...

We should like to emphasize the fact that this therapy is recommended only when the diagnosis of acute intractable bronchial asthma is certain since it might be hazardous if used in the treatment ...

This is crucial as an asthma exacerbation is a sign of a failure of the treatment plan, and is a marker for future exacerbations and risk of death. However, primary care will need updated systems and ...

The Department of Health (DOH) has so far recorded 46 cases of bronchial asthma and acute exacerbation nationwide and this number may still increase amid the New Year festivities. The DOH said the ...

Asthma and COPD exacerbations cause nearly four million deaths worldwide each year, but treatment for the chronic conditions has not changed in five decades, she noted. Reuters ...